close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Curonix LLC

News headline image
Curonix LLC Announces Commercial Availability of the Freedom® Peripheral Nerve Stimulator (PNS) System as the Only Full-Body PNS Therapy Available in the United States for Craniofacial Pain
From Curonix LLC
Via GlobeNewswire
News headline image
Curonix Strengthens Executive Leadership with Appointment of Leading Medical Device Executive Russell Fleeger as Chief Financial Officer to Drive Next Stage of Growth
From Curonix LLC
Via GlobeNewswire
News headline image
Curonix Publishes Results for the First and Only IDE PNS Multi-Center Randomized Clinical Trial Resulting in an FDA 510(k) Expanded Indication for Treating Chronic Craniofacial Pain
From Curonix LLC
Via GlobeNewswire
News headline image
Curonix Expands the Freedom® PNS System Patient Treatment Options with the Launch of its Innovative Wearable Solution for Chronic Pain of the Head, Neck, Shoulder, and Torso
From Curonix LLC
Via GlobeNewswire
News headline image
Curonix leads the PNS market with expanded MR Labeling for 3T Full-Body MRI Scans for its Freedom® Peripheral Nerve Stimulator (PNS) System
From Curonix LLC
Via GlobeNewswire
News headline image
Curonix Unveils NervPulse™ Therapy: Setting a New Standard in Nerve-Specific Peripheral Nerve Stimulation (PNS) Therapy
From Curonix LLC
Via GlobeNewswire
News headline image
Curonix Foundational Clinical Data Published Within the American Society of Interventional Pain Physicians (ASIPP) Peripheral Nerve Stimulation Guidelines for the Management of Chronic Pain
From Curonix LLC
Via GlobeNewswire
News headline image
Curonix Receives the First Full-Body Peripheral Nerve Stimulator (PNS) FDA Clearance, including Craniofacial Pain Indication, for its Freedom® PNS System
From Curonix LLC
Via GlobeNewswire
News headline image
Curonix Partners with Sure Med Compliance to Expand PNS Clinical Evidence
From Curonix LLC
Via GlobeNewswire
News headline image
Curonix Celebrates 1st Anniversary
From Curonix LLC
Via GlobeNewswire
News headline image
Retrospective clinical study highlights the effectiveness of Curonix’s Freedom® PNS System in reducing pain scores and improving patient satisfaction
From Curonix LLC
Via GlobeNewswire
News headline image
Curonix Provides Reimbursement Update on Neurostimulator Procedure Codes
From Curonix LLC
Via GlobeNewswire
News headline image
Independent clinical study shows Curonix’s Freedom® PNS System significantly reduces pain scores and medication usage
From Curonix LLC
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today